These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 5900073

  • 1. [Specific treatment of excessive iron deposition in the tissues].
    Plachecka-Gutowska M, Mikolajew M.
    Pol Arch Med Wewn; 1965; 35(1):111-7. PubMed ID: 5900073
    [No Abstract] [Full Text] [Related]

  • 2. [Specific treatment of excessive iron deposition in the tissues].
    Plachecka-Gutowska M, Mikolajew M.
    Pol Arch Med Wewn; 1965; 35(1):111-7. PubMed ID: 5900060
    [No Abstract] [Full Text] [Related]

  • 3. Hypersiderosis.
    Walsh JR, Mass RE.
    Med Times; 1967 Apr; 95(4):363-9. PubMed ID: 6021601
    [No Abstract] [Full Text] [Related]

  • 4. Studies on iron metabolism with desferrioxamine in man. Experimental and clinical studies.
    Hedenberg L.
    Scand J Haematol Suppl; 1969 Apr; 6():5-86. PubMed ID: 5259199
    [No Abstract] [Full Text] [Related]

  • 5. [Use of chelates for removal of excess iron from the body].
    Meshchanov AIu, Romanova MZh, Kol'tsova GN, Shcherbinina SP.
    Gematol Transfuziol; 1989 Mar; 34(3):40-5. PubMed ID: 2656376
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of the iron chelator desperrioxamine as affected by liposome encapsulation: potential in treatment of chronic hemosiderosis.
    Guilmette RA, Cerny EA, Rahman YE.
    Life Sci; 1978 Jan; 22(4):313-20. PubMed ID: 622008
    [No Abstract] [Full Text] [Related]

  • 7. [Therapeutic results in the treatment of primary and secondary hemochromatoses with Desferal].
    Wöhler F.
    Blut; 1967 Apr; 15(1):33-42. PubMed ID: 6025965
    [No Abstract] [Full Text] [Related]

  • 8. Desferal therapy in iron storage disease.
    Thompson RB, Owen DM, Bell WN.
    Am J Med Sci; 1967 Apr; 253(4):453-60. PubMed ID: 6021380
    [No Abstract] [Full Text] [Related]

  • 9. Iron overload: pathogenesis and treatment with chelating agents.
    Huebers H.
    Blut; 1983 Aug; 47(2):61-7. PubMed ID: 6871476
    [No Abstract] [Full Text] [Related]

  • 10. Iron metabolism and chelation therapy in hemosiderosis.
    Graziano JH.
    Curr Top Hematol; 1978 Aug; 1():127-50. PubMed ID: 400529
    [No Abstract] [Full Text] [Related]

  • 11. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.
    McLaren GD, Muir WA, Kellermeyer RW.
    Crit Rev Clin Lab Sci; 1983 Aug; 19(3):205-66. PubMed ID: 6373141
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of primary idiopathic hemochromatosis and secondary hemosiderosis].
    Strohmeyer G.
    Dtsch Med Wochenschr; 1974 Nov 08; 99(45):2295-9. PubMed ID: 4448138
    [No Abstract] [Full Text] [Related]

  • 13. [Hemochromatosis].
    Simon M, Hespel JP, Brissot P, Fauchet R, Edan G, Le Reun M, Le Mignon L, Genetet B, Bourel M.
    Ann Med Interne (Paris); 1981 Nov 08; 132(6):413-33. PubMed ID: 7032384
    [No Abstract] [Full Text] [Related]

  • 14. Disorders of iron metabolism.
    Nimeh N, Bishop RC.
    Med Clin North Am; 1980 Jul 08; 64(4):631-45. PubMed ID: 6995727
    [Abstract] [Full Text] [Related]

  • 15. [Iron kinetics in hemochromatosis].
    Najean Y, Dresch C.
    Ann Biol Clin (Paris); 1972 Jul 08; 30(4):379-89. PubMed ID: 5082972
    [No Abstract] [Full Text] [Related]

  • 16. [Use of desferal in treatment of sideroses of different origin. (Literature review)].
    Turbina NS.
    Probl Gematol Pereliv Krovi; 1968 Jul 08; 13(7):47-52. PubMed ID: 4898933
    [No Abstract] [Full Text] [Related]

  • 17. Transferrin behaviour in haemochromatosis.
    Blanc B, Vannotti A.
    Nature; 1966 Oct 29; 212(5061):480-1. PubMed ID: 5970180
    [No Abstract] [Full Text] [Related]

  • 18. Blood and neoplastic diseases: treatment of iron deficiency and iron overload.
    Dagg JH.
    Br Med J; 1974 Jun 01; 2(5917):494-7. PubMed ID: 4834105
    [No Abstract] [Full Text] [Related]

  • 19. Chelation therapy for iron overload.
    Nutr Rev; 1980 May 01; 38(5):185-7. PubMed ID: 7207885
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of desferrioxamine B and 2-(beta-aminoethoxy)cyclohexylaminetetraacetate in experimental hemochromatosis in rats and in primary hemochromatosis of man].
    Bohne F, Lessmann J.
    Arzneimittelforschung; 1969 Jun 01; 19(6):944-7. PubMed ID: 5820039
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.